Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid ...

By Rishika Sadam and Bhanvi Satija (Reuters) -Japanese drugmaker Takeda Pharmaceutical is exploring the option of conducting ...

Dr. Hussein Tawbi, who works for MD Anderson in Houston, said there are two things he hopes people take away from the story ...

Vascular toxicity associated with cancer therapies is a leading cause of cardiovascular adverse events in patients with ...

A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back, a small ...

Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.

SHELTON, CONNECTICUT / ACCESS Newswire / August 18, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC ...

Private equity firm THL Partners has agreed to buy a majority stake in Headlands Research, a U.S.-based network of clinical ...

In this episode presented by Cresset, BioSpace’s head of insights Lori Ellis discusses clinical trial fail rates and AI’s ...

Onward Medical has received FDA approval to begin a pivotal study of its Arc-IM system, an implantable neurostimulation therapy designed to treat blood pressure instability after spinal cord injury, ...

Dr. Miller said he was optimistic that the clinical trial results would support an F.D.A. approval, but if or when that might happen is unclear, especially given recent changes at the agency.

A team at the University of Virginia has developed a monoclonal antibody to stop sepsis, the leading cause of death in U.S. hospitals.